Embecta (EMBC) vs KORU Medical Systems (KRMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
KORU Medical Systems (KRMD) has outperformed Embecta (EMBC) over the past year, losing 24.2% versus a loss of 57.1%. Embecta is the larger company by market cap ($329.5 million vs $138.5 million), about 2.4 times the size. On valuation, Embecta trades at a lower forward P/E (3.3x vs 86.1x for KORU Medical Systems).
Embecta pays a dividend yielding 7.91%, while KORU Medical Systems does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EMBC | KRMD |
|---|---|---|
| Share price | $5.82 | $3.02 |
| Market cap | $329.48M | $138.49M |
| 1-day change | -1.61% | +1.17% |
| YTD return | -50.25% | -48.71% |
| 1-year return | -57.11% | -24.17% |
| 5-year return | — | +3.83% |
| P/E ratio (TTM) | 3.96 | — |
| Forward P/E | 3.30 | 86.14 |
| EPS (TTM) | $1.47 | $-0.04 |
| Dividend yield | 7.91% | 0.00% |
| Annual dividend | $0.46 | $0.00 |
| 52-week high | $14.91 | $6.61 |
| 52-week low | $2.77 | $2.86 |
| Distance from 52-week high | -61.00% | -54.37% |
| Analyst consensus | none | none |
| Avg. price target upside | -31.21% | +107.30% |
| Average volume | 1.37M | 232.65K |
| Shares outstanding | 56.66M | 45.93M |
| Employees | 1,850 | 73 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Embecta is about 2.4 times larger than KORU Medical Systems by market value ($329.48M vs $138.49M).
- KRMD has outperformed EMBC by 32.9 percentage points over the past year.
- Embecta offers a meaningfully higher dividend yield (7.91% vs 0.00%).
About Embecta
EMBC stock →Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.
Health Care · Medical/Dental Instruments · 1,850 employees
About KORU Medical Systems
KRMD stock →KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.
Health Care · Medical/Dental Instruments · 73 employees
EMBC vs KRMD FAQ
Which is bigger, Embecta or KORU Medical Systems?
Embecta (EMBC) is larger, with a market capitalization of $329.48M compared with $138.49M for KORU Medical Systems (KRMD).
Which stock has performed better over the past year, EMBC or KRMD?
KRMD returned -24.17% over the past 12 months, compared with -57.11% for EMBC (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Embecta or KORU Medical Systems?
Embecta pays a dividend yielding 7.91%, while KORU Medical Systems does not currently pay a regular dividend.
Are Embecta and KORU Medical Systems in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.